Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Loteprednol etabonate ophthalmic preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loteprednol etabonate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely loteprednol etabonate 5 milligram/1 milliliter conventional release eye suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loteprednol etabonate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Loteprednol etabonate 2 mg/mL eye suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loteprednol etabonate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Loteprednol etabonate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loteprednol etabonate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Loteprednol etabonate + tobramycin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loteprednol etabonate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Loteprednol etabonate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Loteprednol etabonate 2 mg/mL eye suspension |
Has precise active ingredient |
True |
Loteprednol etabonate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Loteprednol etabonate 2 mg/mL eye suspension |
Has basis of strength substance (attribute) |
True |
Loteprednol etabonate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely loteprednol etabonate 5 milligram/1 milliliter conventional release eye suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Loteprednol etabonate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely loteprednol etabonate 5 milligram/1 milliliter conventional release eye suspension (clinical drug) |
Has precise active ingredient |
True |
Loteprednol etabonate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension |
Has precise active ingredient |
True |
Loteprednol etabonate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension |
Has basis of strength substance (attribute) |
True |
Loteprednol etabonate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |